Table 1 Demographic and clinicopathological characteristics of our study population (n = 100 patients)
From: The value of liver resection for focal nodular hyperplasia: resection yes or no?
Variables | Median (range) or n (%) |
|---|---|
Demographics | |
Age (years) | 44 (21–71) |
Body mass index (kg/m2) | 24.9 (17.6–35.3) |
Gender | |
Female | 89 (89 %) |
Male | 11 (11 %) |
Laboratory values | |
ASAT (µmmol/l) | 0.39 (0.2–1.15) |
ALAT (µmmol/l) | 0.36 (0.15–1.7) |
y-glutamyltransferase (µmmol/l) | 1.4 (0.1–9.6) |
Bilirubin (µmol/l) | 8.7 (2–30) |
Alkaline phosphatase (µmol/l) | 2.5 (0.7–7.1) |
Prothrombin time (%) | 104 (58–134) |
Pathology | |
Typical FNH | 80 (80 %) |
Non-classical FNH | 20 (20 %) |
Tumor size (cm) | 5.9 (2–17) |
Tumor distribution | |
Unilobular | 76 (76 %) |
Multilobular | 24 (24 %) |
Tumor weight (g) | 366.5 (10–1886) |
Number of tumor lesions | 1.59 (1–7) |
Medical history | |
Previous hormone therapy | |
Yes | 67 (67 %) |
No | 33 (33 %) |
Median time of hormone use (years) | 18 (1–35) |
Other medicaments (aspirine, steroids, antidepressants) | 14 (14 %) |
History of cancer | |
Yes | 18 (18 %) |
No | 82 (82 %) |